Skye Bioscience, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2013 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Skye Bioscience, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2013 to Q3 2024.
  • Skye Bioscience, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 6, 2024 was 30.3M shares, a 146% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 30.3M +18M +146% Nov 6, 2024 10-Q 2024-11-07
Q2 2024 30.3M -941M -96.9% Aug 8, 2024 10-Q 2024-08-09
Q1 2024 28.1M -943M -97.1% Mar 20, 2024 10-K 2024-03-22
Q3 2023 12.3M -900M -98.6% Nov 12, 2023 10-Q 2023-11-14
Q2 2023 972M +476M +95.9% Aug 4, 2023 10-Q 2023-08-07
Q1 2023 972M +476M +95.9% Mar 29, 2023 10-K 2023-03-31
Q3 2022 912M +436M +91.6% Nov 11, 2022 10-Q 2022-11-14
Q2 2022 496M +78.7M +18.9% Aug 12, 2022 10-Q 2022-08-15
Q1 2022 496M +124M +33.3% Mar 24, 2022 10-K 2022-03-28
Q3 2021 476M +226M +90.4% Nov 8, 2021 10-Q 2021-11-10
Q2 2021 417M +178M +74.2% Aug 4, 2021 10-Q 2021-08-06
Q1 2021 372M +189M +103% May 5, 2021 10-Q 2021-05-07
Q3 2020 250M +116M +86.5% Nov 5, 2020 10-Q 2020-11-06
Q2 2020 240M +105M +78.6% Aug 12, 2020 10-Q 2020-08-13
Q1 2020 183M +49.3M +36.8% Mar 16, 2020 10-K 2020-03-23
Q3 2019 134M +225K +0.17% Nov 12, 2019 10-Q 2019-11-14
Q2 2019 134M +1.39M +1.05% Aug 7, 2019 10-Q 2019-08-09
Q1 2019 134M +33.8M +33.8% Mar 13, 2019 10-K 2019-03-14
Q3 2018 134M +103M +332% Nov 13, 2018 10-Q 2018-11-14
Q2 2018 133M +102M +334% Aug 9, 2018 10-Q 2018-08-10
Q1 2018 100M +74.3M +289% Mar 15, 2018 10-K 2018-03-19
Q3 2017 31M +10.2M +48.9% Nov 14, 2017 10-Q 2017-11-14
Q2 2017 30.6M +10.7M +53.6% Aug 10, 2017 10-Q 2017-08-11
Q1 2017 25.7M +5.83M +29.3% Mar 7, 2017 10-K 2017-03-10
Q3 2016 20.8M +1.52M +7.89% Nov 8, 2016 10-Q 2016-11-09
Q2 2016 19.9M +3.65M +22.4% Aug 12, 2016 10-Q 2016-08-12
Q1 2016 19.9M +3.64M +22.4% Mar 14, 2016 10-K 2016-03-21
Q3 2015 19.3M +15.7M +432% Nov 12, 2015 10-Q 2015-11-12
Q2 2015 16.3M +12.6M +349% Aug 14, 2015 10-Q 2015-08-14
Q1 2015 16.3M +12.6M +349% Mar 23, 2015 10-K 2015-03-27
Q3 2014 3.62M +476K +15.1% Sep 11, 2014 10-Q 2014-09-15
Q2 2014 3.62M +476K +15.1% Jun 4, 2014 10-Q 2014-06-05
Q1 2014 3.62M Mar 13, 2014 10-Q 2014-03-17
Q4 2013 3.62M Jan 22, 2014 10-K 2014-01-27
Q3 2013 3.15M Sep 9, 2013 10-Q 2013-09-16
Q2 2013 3.15M Jun 14, 2013 10-Q 2013-06-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.